BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 26210602)

  • 1. Re: Lepore et al.: Intravitreal bevacizumab versus laser treatment in type 1 retinopathy of prematurity: report on fluorescein angiographic findings (Ophthalmology 2014;121:2212-9).
    Yetik H
    Ophthalmology; 2015 Aug; 122(8):e49. PubMed ID: 26210602
    [No Abstract]   [Full Text] [Related]  

  • 2. Re: Lepore et al.: Intravitreal bevacizumab versus laser treatment in type 1 retinopathy of prematurity: report on fluorescein angiographic findings (Ophthalmology 2014;121:2212-9).
    Padhi TR; Besirli CG
    Ophthalmology; 2015 Aug; 122(8):e47-8. PubMed ID: 26210600
    [No Abstract]   [Full Text] [Related]  

  • 3. Intravitreal bevacizumab versus laser treatment in type 1 retinopathy of prematurity: report on fluorescein angiographic findings.
    Lepore D; Quinn GE; Molle F; Baldascino A; Orazi L; Sammartino M; Purcaro V; Giannantonio C; Papacci P; Romagnoli C
    Ophthalmology; 2014 Nov; 121(11):2212-9. PubMed ID: 25001158
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intravitreal bevacizumab following laser therapy for severe retinopathy of prematurity.
    Erol N; Gürsoy H; Sahin A; Basmak H
    J Pediatr Ophthalmol Strabismus; 2010 Aug; 47 Online():e1-4. PubMed ID: 21158371
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Author reply: To PMID 25001158.
    Lepore D; Quinn GE
    Ophthalmology; 2015 Aug; 122(8):e49-50. PubMed ID: 26210603
    [No Abstract]   [Full Text] [Related]  

  • 6. Author reply: To PMID 25001158.
    Lepore D; Quinn GE
    Ophthalmology; 2015 Aug; 122(8):e48. PubMed ID: 26210601
    [No Abstract]   [Full Text] [Related]  

  • 7. Bevacizumab versus diode laser in stage 3 posterior retinopathy of prematurity.
    Moran S; O'Keefe M; Hartnett C; Lanigan B; Murphy J; Donoghue V
    Acta Ophthalmol; 2014 Sep; 92(6):e496-7. PubMed ID: 24428792
    [No Abstract]   [Full Text] [Related]  

  • 8. Exudative retinopathy and detachment: a late reactivation of retinopathy of prematurity after intravitreal bevacizumab.
    Ittiara S; Blair MP; Shapiro MJ; Lichtenstein SJ
    J AAPOS; 2013 Jun; 17(3):323-5. PubMed ID: 23607977
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined intravitreal bevacizumab injection and zone I sparing laser photocoagulation in patients with zone I retinopathy of prematurity.
    Kim J; Kim SJ; Chang YS; Park WS
    Retina; 2014 Jan; 34(1):77-82. PubMed ID: 23807184
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Successful Surgical Management of Retinopathy of Prematurity Showing Rapid Progression despite Extensive Retinal Photocoagulation.
    Gadkari SS; Kulkarni SR; Kamdar RR; Deshpande M
    Middle East Afr J Ophthalmol; 2015; 22(3):393-5. PubMed ID: 26180484
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcomes after Intravitreal Bevacizumab versus Laser Photocoagulation for Retinopathy of Prematurity: A 5-Year Retrospective Analysis.
    Hwang CK; Hubbard GB; Hutchinson AK; Lambert SR
    Ophthalmology; 2015 May; 122(5):1008-15. PubMed ID: 25687024
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acquired vasoproliferative retinal tumor: a late sequela of retinopathy of prematurity.
    Chow CC; Blair MP; Shapiro MJ
    Arch Ophthalmol; 2011 Sep; 129(9):1234-5. PubMed ID: 21911679
    [No Abstract]   [Full Text] [Related]  

  • 13. Management of retinopathy of prematurity.
    Fleck BW
    Arch Dis Child Fetal Neonatal Ed; 2013 Sep; 98(5):F454-6. PubMed ID: 23813885
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intravitreal bevacizumab for exudative retinal detachment post laser therapy for retinopathy of prematurity.
    Ehmann D; Greve M
    Can J Ophthalmol; 2014 Apr; 49(2):228-31. PubMed ID: 24767234
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Retinopathy of prematurity - therapy. Part 2].
    Prepiaková Z; Tomčíková D; Kostolná B; Gerinec A
    Cesk Slov Oftalmol; 2014 Apr; 70(2):50-4. PubMed ID: 25030312
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of type 1 retinopathy of prematurity with bevacizumab versus laser.
    Isaac M; Mireskandari K; Tehrani N
    J AAPOS; 2015 Apr; 19(2):140-4. PubMed ID: 25892041
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Re: Lepore et al.: Follow-up to age 4 years of treatment of type 1 retinopathy of prematurity intravitreal bevacizumab injection versus laser: fluorescein angiographic findings (Ophthalmology. 2018;125:218-226).
    Blair MP; Hilkert Rodriguez S; Chan RVP; Shapiro MJ
    Ophthalmology; 2018 Oct; 125(10):e70-e71. PubMed ID: 30243341
    [No Abstract]   [Full Text] [Related]  

  • 18. [Retinopathy of prematurity].
    Jandeck C; Stahl A
    Klin Monbl Augenheilkd; 2012 May; 229(5):559-75; quiz 576-7. PubMed ID: 22592347
    [No Abstract]   [Full Text] [Related]  

  • 19. Bilateral effect of unilateral bevacizumab injection in retinopathy of prematurity.
    Karaca C; Oner AO; Mirza E; Polat OA; Sahiner M
    JAMA Ophthalmol; 2013 Aug; 131(8):1099-101. PubMed ID: 23744183
    [No Abstract]   [Full Text] [Related]  

  • 20. A rare association of intravitreal bevacizumab injection with double ridge formation in retinopathy of prematurity.
    Yaz Y; Erol N; Gursoy H; Basmak H; Bilgec MD
    J Pediatr Ophthalmol Strabismus; 2014 Oct; 51 Online():e66-8. PubMed ID: 25333243
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.